RE:RE:RE:RE:RE:RE:RE:RE:Light at the end of the Tunnel I'm no expert but I would say the value reflects the way the company runs. I alongside others am not happy with executive compensation and the way it's handled. Others are not happy with the pace of the trial. Many other reasons have been mentioned. That's why it's trading at a discount.